Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Mizuho Maintains Buy on Universal Health Services, Lowers Price Target to $121

Mizuho analyst Ann Hynes maintains Universal Health Services (NYSE:UHS) with a Buy and lowers the price target from $153 to $121.
byBenzinga Newsdesk
July 1, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Mizuho analyst Ann Hynes maintains Universal Health Services (NYSE:UHS) with a Buy and lowers the price target from $153 to $121.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Sutro Biopharma Earlier Announced Luvelta Demonstrated Encouraging Preliminary Anti-Tumor Activity (29% Response Rate) In Late-stage Patients With Recurrent/relapsed Endometrial Cancer With Tumor Proportion Score (TPS) >25% Folrα Expression

By Charles Gross
October 22, 11:17 AM
Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ:STRO), a clinical-stage oncology company pioneering site-specific and novel-format antibody drug conjugates (ADCs), today announced initial results from a Phase 1

STRO